KROS
#3451
Keros Therapeutics, Inc. - common stock
11.6 1 USD
-0.03%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-2.85%
Variación mensual
+4.59%
Variación en los últimos 6 meses
+3.85%
Cambio anual
-23.11%
Cierres anteriores
11.9 5
Open
11.8 9
Mínimo
11.5 8
Máximo
12.0 8
Financials
- Market Capitalization 230.19 M
- Employee 92
- Founded 2015
- CEO N/A
- Website www.kerostx.com
- Headquarter Massachusetts, United States
- FIGI BBG00H1HP9G9
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
8.85
Relación precio/flujo de caja
3.16
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 3426 |  MGNX MacroGenics, Inc. - Common Stock | 3.72 USD | -0.53% | -1.85% | -7.00% | +131.06% | 236.96 M USD | ||
| 3444 |  ALEC Alector, Inc. - Common Stock | 2.08 USD | 0.00% | 0.00% | -3.26% | -30.67% | 232.25 M USD | ||
| 3469 |  PLX Protalix BioTherapeutics, Inc. Common Stock | 2.78 USD | +0.72% | +3.73% | +6.11% | -4.79% | 223.99 M USD | ||
| 3478 |  EVMN Evommune, Inc. Common Stock | 6.07 USD | -2.88% | -8.72% | -42.57% | -64.95% | 220.29 M USD |